Malaria is still an important challenge for global public health because of its extensive mortality and morbidity. Plasmodium ovale is mainly distributed in tropical regions of Africa and Asia. it includes two distinct ovale malaria species, which are P. ovale curtisi and P. ovale wallikeri. Apical membrane antigen-1 (AMA-1) is an asexual blood-stage protein which is essential for Plasmodium. Thus far, no study on gene polymorphism and immunogenicity of P. ovale AMA-1 (PoAMA-1) has been conducted. Amplified poama1 gene products from 14 P ovale curtisi samples and 12 P ovale wallikeri samples imported from Africa to Jiangsu Province, China were sequenced and their polymorphisms were analyzed.
Anopheles sinensis is the most widely distributed species which mainly transmit the Plasmodium vivax malaria in China. Transgenic techniques have been successfully established in many other mosquitoes, but not previously reported in An. sinensis. In this study, the piggyBac transposable element vector pBac[3xP3‐EGFP afm] and the piggyBac helper plasmid phspBac were coinjected into preblastoderm eggs of An. sinensis, and the progenies were screened for eye EGFP fluorescence using a fluorescence microscope.
In December 2019, a new viral outbreak appeared in central China, in Wuhan province. This coronavirus disease (COVID-19) spread within few months over all continents, causing numerous deaths and seriously disrupting both social and economic life.
CD36 is a multifunctional receptor in cells that plays a role in important cellular processes including immune regulation. Evidence indicates that mutations in the CD36 gene are associated with malaria. Moreover, studies on the frequency of CD36 deficiency have been conducted in specific provinces of China. However, the frequency of CD36 deficiency may differ among various ethnic populations. In this study, we analyzed the frequency of CD36 deficiency among seven different provinces and minorities in China.
Clinical trials of hydroxychloroquine (HCQ) for the treatment of coronavirus infection-2019 (COVID-19) are moving forward on the heels of conflicting, and sometimes controversial, observational studies out of China and France from the first months of the pandemic.
The chloroquine (CQ) and its analogue hydroxychloroquine (HCQ) have been used as frontline drugs for treatment and prophylaxis against all types of human malaria worldwide. Since late December 2019, humans have been under threat due to an outbreak of a novel coronavirus (SARS-CoV-2) disease (COVID-19; previously known as 2019-nCoV), since its first reported cases in Wuhan, China .
Shandong Province, China, has been implementing a malaria elimination program. In this study, we analyzed the epidemiological characteristics of malaria imported into Shandong Province between 2012 and 2017 to provide scientific data for the elimination of malaria. In this epidemiological study, we examined the status of malaria in 2012–2017 in Shandong Province, China.
Plasmodium vivax is the most widely distributed malaria parasite, and its drug resistance poses unique challenges to malaria elimination. The Greater Mekong Subregion (GMS) is known as the global epicenter of multidrug resistance. Surveillance of molecular markers associated with drug resistance in this area will help to inform drug policy.
About half of the world’s population risks contracting malaria, which despite the effective treatments available globally, remains a life-threatening affliction, particularly for the poorest and most vulnerable populations. To raise awareness, advocacy, and action towards defeating the disease, which was responsible for approximately 228 million debilitating infections and 405 000 deaths at last count in 2018, the international community has, since 2008, commemorated World Malaria Day on 25 April.
In order to monitor progress towards malaria elimination, it is crucial to be able to measure changes in spatio-temporal transmission. However, common metrics of malaria transmission such as parasite prevalence are under powered in elimination contexts. China has achieved major reductions in malaria incidence and is on track to eliminate, having reporting zero locally-acquired malaria cases in 2017 and 2018. Understanding the spatio-temporal pattern underlying this decline, especially the relationship between locally-acquired and imported cases, can inform efforts to maintain elimination and prevent re-emergence.